Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CKPT

Checkpoint Therapeutics Inc

Jul 26 • 04:00PM ET

2.57

Dollar change -0.09
Percentage change -3.38	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.37	Insider Own	20.34%	Shs Outstand	38.08M	Perf Week	-0.39%
Market Cap	97.87M	Forward P/E	85.67	EPS next Y	0.03	Insider Trans	-0.79%	Shs Float	30.34M	Perf Month	24.15%
Income	-52.32M	PEG	-	EPS next Q	-0.30	Inst Own	14.61%	Short Float	12.98%	Perf Quarter	80.99%
Sales	0.07M	P/S	1398.08	EPS this Y	60.15%	Inst Trans	1.28%	Short Ratio	9.68	Perf Half Y	50.29%
Book/sh	-0.29	P/B	-	EPS next Y	102.37%	ROA	-585.51%	Short Interest	3.94M	Perf Year	-21.41%
Cash/sh	0.30	P/C	8.71	EPS next 5Y	-	ROE	-	52W Range	1.30 - 3.62	Perf YTD	12.23%
Dividend Est.	-	P/FCF	-	EPS past 5Y	26.32%	ROI	-	52W High	-29.01%	Beta	1.21
Dividend TTM	-	Quick Ratio	0.54	Sales past 5Y	-47.67%	Gross Margin	-	52W Low	97.69%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	0.54	EPS Y/Y TTM	58.74%	Oper. Margin	-66195.59%	RSI (14)	60.23	Volatility	9.11% 7.90%
Employees	23	Debt/Eq	-	Sales Y/Y TTM	-61.14%	Profit Margin	-76938.24%	Recom	1.00	Target Price	21.67
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	62.71%	Payout	-	Rel Volume	1.16	Prev Close	2.66
Sales Surprise	-100.00%	EPS Surprise	-20.57%	Sales Q/Q	-100.00%	Earnings	May 10 BMO	Avg Volume	406.63K	Price	2.57
SMA20	9.06%	SMA50	23.17%	SMA200	26.90%	Trades		Volume	471,188	Change	-3.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-14-22	Resumed	B. Riley Securities	Buy	$7
Jun-09-21	Initiated	B. Riley Securities	Buy	$18
Jan-20-21	Initiated	Cantor Fitzgerald	Overweight	$16
May-29-19	Initiated	Lake Street	Buy
Dec-08-17	Initiated	H.C. Wainwright	Buy	$11

Jul-25-24 07:30AM	Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma (GlobeNewswire) +7.04%
Jul-15-24 08:00AM	GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research (GlobeNewswire) +6.81%
Jul-02-24 08:00AM	Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
07:00AM	Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab (GlobeNewswire)
Jun-24-24 07:30AM	Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission (GlobeNewswire) +15.56%
04:15PM	Loading…
May-15-24 04:15PM	Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) +9.20%
May-13-24 08:30AM	Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference (GlobeNewswire)
May-10-24 01:52PM	CKPT Stock Earnings: Checkpoint Therapeutics Misses EPS for Q1 2024 (InvestorPlace)
08:30AM	Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates (GlobeNewswire)
Mar-28-24 04:05PM	Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-22-24 02:52PM	CKPT Stock Earnings: Checkpoint Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
08:30AM	Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-18-24 08:00AM	Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors (GlobeNewswire)
Jan-29-24 08:00AM	Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) +18.45%
Jan-11-24 08:15AM	Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference (GlobeNewswire)
07:31AM	Loading…
Dec-18-23 07:31AM	UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy (Reuters) -44.88%
07:09AM	US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy (Reuters)
07:00AM	U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer (GlobeNewswire)
Dec-11-23 12:26PM	3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 (InvestorPlace)
Dec-05-23 08:30AM	Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance (GlobeNewswire)
Nov-13-23 05:00PM	Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) +6.63%
Oct-18-23 08:30AM	Checkpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer (GlobeNewswire)
Oct-02-23 12:53PM	Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds (GlobeNewswire) -5.29%
Sep-21-23 08:30AM	Checkpoint Therapeutics to Participate in the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 08:30AM	Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-14-23 04:15PM	Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
04:01PM	Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Jul-31-23 08:00AM	Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) -16.45%
Jul-27-23 07:00AM	Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results Demonstrating Substantial Increases in Complete Response Rates in Advanced Cutaneous Squamous Cell Carcinoma (GlobeNewswire) -13.15%
Jun-28-23 08:00AM	Checkpoint Therapeutics Announces Presentation of New Cosibelimab Pharmacokinetic Data Supporting Extended-Interval Dosing (GlobeNewswire)
08:30AM	Loading…
May-23-23 08:30AM	Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
May-21-23 10:03AM	3 Stocks With 1,000% Upside Potential (InvestorPlace)
May-15-23 04:15PM	Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) +8.02%
04:01PM	Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Apr-02-23 08:37AM	Checkpoint Therapeutics Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Mar-31-23 08:00AM	Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -32.84%
Mar-30-23 08:00PM	Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
04:10PM	Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-02-23 07:00AM	Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma (GlobeNewswire)
Feb-21-23 08:00AM	Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -7.82%
Jan-17-23 08:30AM	Checkpoint Therapeutics to Participate in the B. Riley Securities 3rd Annual Oncology Conference (GlobeNewswire) -8.16%
Jan-04-23 08:00AM	Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma (GlobeNewswire) +8.47%
Jan-01-23 09:36AM	Individual investors in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) are its biggest bettors, and their bets paid off as stock gained 36% last week (Simply Wall St.)
Dec-15-22 08:00AM	Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -17.01%
Dec-05-22 04:30PM	Checkpoint Therapeutics Announces Reverse Stock Split (GlobeNewswire) -9.50% -22.84%
Nov-08-22 04:30PM	Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Sep-22-22 08:30AM	Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Sep-08-22 08:15AM	Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-12-22 08:00AM	Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Jun-30-22 10:19AM	We're Keeping An Eye On Checkpoint Therapeutics' (NASDAQ:CKPT) Cash Burn Rate (Simply Wall St.)
Jun-16-22 09:29AM	Checkpoint' Cancer Therapy Shows Almost 55% Response Rate In Skin Cancer Patients (Benzinga)
07:30AM	Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma (GlobeNewswire)
Jun-06-22 04:30PM	Checkpoint Therapeutics Announces Presentation of Pivotal Trial Results of Cosibelimab at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -8.28%
May-19-22 08:30AM	Checkpoint Therapeutics to Participate in the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-13-22 08:30AM	Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency (GlobeNewswire) +17.43%
May-12-22 04:30PM	Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire) +11.86%
Apr-28-22 08:00AM	Checkpoint Therapeutics Announces Data Presentation of Pivotal Trial Results of Cosibelimab to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-04-22 08:15AM	Checkpoint Therapeutics to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities (GlobeNewswire)
Apr-01-22 08:30AM	Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022 (GlobeNewswire)
Mar-31-22 07:10PM	Here's What Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Mar-28-22 07:30AM	Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-10-22 10:55AM	2 Strong Buy Penny Stocks With Over 300% Upside Potential (TipRanks) +13.77%
Jan-26-22 10:00AM	2 Biotech Stocks That Could Be 10-Baggers in 2022 (Motley Fool)
Jan-25-22 04:30PM	Checkpoint Therapeutics to Participate in the B. Riley Securities Virtual Oncology Conference (GlobeNewswire) +12.33%
11:04AM	Checkpoint Therapeutics' Cosibelimab Posts 47.4% ORR In Skin Cancer Patients (Benzinga)
10:06AM	Why Checkpoint Therapeutics Stock Is Heating Up Today (Motley Fool)
07:30AM	Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma (GlobeNewswire)
Dec-08-21 08:30AM	Checkpoint Therapeutics Announces Initiation of CONTERNO Phase 3 Trial of Cosibelimab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer (GlobeNewswire) +5.48%
Nov-04-21 04:30PM	Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results (GlobeNewswire)
07:50AM	A Look At The Intrinsic Value Of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) (Simply Wall St.)
Sep-22-21 08:30AM	Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference (GlobeNewswire)
Sep-09-21 08:30AM	Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-06-21 02:13AM	Checkpoint Therapeutics (NASDAQ:CKPT) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Aug-05-21 04:30PM	Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Jul-08-21 08:30AM	Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference (GlobeNewswire)
Jun-09-21 06:01PM	Why Checkpoint Therapeutics Skyrocketed Today (Motley Fool) +19.17%
08:02AM	5 Top Stock Gainers for Wednesday: SPI Energy, Checkpoint Therapeutics (TheStreet.com)
05:49AM	Checkpoint Therapeutics Soars on B. Riley Buy Rating, $18 Price Target (TheStreet.com)
Jun-03-21 08:00AM	Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics (Benzinga)
May-12-21 08:00AM	Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma (GlobeNewswire)
May-08-21 04:23AM	What Is The Ownership Structure Like For Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)? (Simply Wall St.)
May-06-21 04:15PM	Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights (GlobeNewswire) -14.18% +6.36%
Mar-09-21 04:30PM	Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights (GlobeNewswire)
01:19AM	Did You Miss Checkpoint Therapeutics' (NASDAQ:CKPT) 84% Share Price Gain? (Simply Wall St.)
Mar-04-21 08:00AM	Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference (GlobeNewswire) -8.86%
Mar-01-21 08:30AM	Checkpoint Therapeutics Announces Formation of Scientific Advisory Board (GlobeNewswire)
Feb-11-21 11:16AM	These 2 Penny Stocks Could Rack up Triple-Digit Gains, Say Analysts (TipRanks) +12.13%
Jan-06-21 08:30AM	Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences (GlobeNewswire)
Dec-09-20 12:15AM	Here's Why We're Not Too Worried About Checkpoint Therapeutics' (NASDAQ:CKPT) Cash Burn Situation (Simply Wall St.) -5.35%
Nov-27-20 01:06PM	Is Checkpoint Therapeutics, Inc. (CKPT) A Good Stock To Buy? (Insider Monkey)
Nov-09-20 08:00AM	Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting (GlobeNewswire)
Nov-04-20 04:25PM	Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-02-20 07:00AM	Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab (PR Newswire)
Oct-25-20 09:08AM	What Kind Of Shareholders Hold The Majority In Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shares? (Simply Wall St.)
Sep-19-20 10:01AM	How Much Did Checkpoint Therapeutics'(NASDAQ:CKPT) Shareholders Earn From Share Price Movements Over The Last Three Years? (Simply Wall St.)
Sep-17-20 05:27PM	Checkpoint Therapeutics Announces $20.0 Million Bought Deal Offering (GlobeNewswire) -17.22%
06:30AM	Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma (GlobeNewswire)
Sep-14-20 07:19AM	Checkpoint Therapeutics To Release Significant Drug Data At This Week's ESMO Congress (Benzinga)
Sep-10-20 08:00AM	Checkpoint Therapeutics to Participate in Three September 2020 Virtual Investor Conferences (GlobeNewswire) +13.36%
Sep-08-20 10:02AM	CKPT: Checkpoints Got Skin in the Game: Interim Results Next Week (Zacks Small Cap Research) +10.60%

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Oliviero James F III	CEO, President and Director	Jun 26 '24	Sale	2.05	24,610	50,450	1,977,170	Jun 28 08:01 PM
GRAY WILLIAM GARRETT	Chief Financial Officer	Jun 26 '24	Sale	2.06	13,038	26,858	672,186	Jun 28 08:00 PM
Oliviero James F III	CEO, President and Director	Feb 28 '24	Sale	2.06	5,894	12,142	350,836	Mar 01 08:31 PM
GRAY WILLIAM GARRETT	Chief Financial Officer	Feb 28 '24	Sale	2.07	2,035	4,212	145,224	Mar 01 08:30 PM
Oliviero James F III	CEO, President and Director	Feb 01 '24	Sale	2.01	11,900	23,919	369,680	Feb 02 08:10 PM
GRAY WILLIAM GARRETT	Chief Financial Officer	Feb 01 '24	Sale	1.95	4,115	8,024	147,259	Feb 02 08:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CKPT

Checkpoint Therapeutics Inc

Upgrade your FINVIZ experience